SGLT-2 inhibitors may primarily drive growth of branded heart failure treatment market: GlobalData
Approximately 55 per cent of type T2D patients suffer from cardiovascular disease (CVD), which often leads to further…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.